Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity

Molecular Therapy Nucleic Acids

Volumn 2, Issue OCT, 2013, Pages

  Munoz, Jessian L ^a,b   Bliss, Sarah A ^a,b   Greco, Steven J ^b   Ramkissoon, Shakti H ^c,d   Ligon, Keith L ^c,d   Rameshwar, Pranela ^b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

and miRNAs; shRNAs; therapeutic proof of concept siRNAs

Indexed keywords

CASPASE; CYANINE DYE; MICRORNA 9; MICRORNA 9 ANTIBODY; MULTIDRUG RESISTANCE PROTEIN 1; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL COMMUNICATION; CELL DEATH; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; EXOSOME; GLIOBLASTOMA; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84886625070     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2013.60     Document Type: Article

References (27)

1. Yamada, R and Nakano, I (2012). Glioma stem cells: their role in chemoresistance. World Neurosurg 77: 237-240.
2. Chou, CW, Wang, CC, Wu, CP, Lin, YJ, Lee, YC, Cheng, YW et al. (2012). Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1. Neuro-oncology 14: 1227-1238.
3. Bao, L, Hazari, S, Mehra, S, Kaushal, D, Moroz, K and Dash, S (2012). Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. Am J Pathol 180: 2490-2503.
4. Abba, M, Mudduluru, G and Allgayer, H (2012). MicroRNAs in cancer: small molecules, big chances. Anticancer Agents Med Chem 12: 733-743.
5. Martino, S, di Girolamo, I, Orlacchio, A, Datti, A and Orlacchio, A (2009). MicroRNA implications across neurodevelopment and neuropathology. J Biomed Biotechnol 2009: 654346.
6. John-Aryankalayil, M, Palayoor, ST, Makinde, AY, Cerna, D, Simone, CB 2nd, Falduto, MT et al. (2012). Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells. Radiat Res 178: 105-117.
7. Kim, TM, Huang, W, Park, R, Park, PJ and Johnson, MD (2011). A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. Cancer Res 71: 3387-3399.
8. Schaich, M, Kestel, L, Pfirrmann, M, Robel, K, Illmer, T, Kramer, M et al. (2009). A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients. Ann Oncol 20: 175-181.
9. Auffinger, B, Thaci, B, Ahmed, A, Ulasov, I and Lesniak, MS (2013). MicroRNA targeting as a therapeutic strategy against glioma. Curr Mol Med 13: 535-542.
10. Pendleton, C, Li, Q, Chesler, DA, Yuan, K, Guerrero-Cazares, H and Quinones-Hinojosa, A (2013). Mesenchymal stem cells derived from adipose tissue vs bone marrow: in vitro comparison of their tropism towards gliomas. PLoS ONE 8: e58198.
11. Auffinger, B, Thaci, B, Nigam, P, Rincon, E, Cheng, Y and Lesniak, MS (2012). New therapeutic approaches for malignant glioma: in search of the Rosetta stone. F1000 Med Rep 4: 18.
12. Bexell, D, Svensson, A and Bengzon, J (2013). Stem cell-based therapy for malignant glioma. Cancer Treat Rev 39: 358-365.
13. Forbes, GM, Sturm, MJ, Leong, RW, Sparrow, MP, Segarajasingam, D, Cummins, AG et al. (2013). A phase 2 study of allogeneic mesenchymal stromal cells for luminal crohn's disease refractory to biologic therapy. Clin Gastroenterol Hepatol .
14. Greco, SJ and Rameshwar, P (2012). Mesenchymal stem cells in drug/gene delivery: implications for cell therapy. Ther Deliv 3: 997-1004.
15. Matuskova, M, Hlubinova, K, Pastorakova, A, Hunakova, L, Altanerova, V, Altaner, C et al. (2010). HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells. Cancer Lett 290: 58-67.
16. Chagastelles, PC, Nardi, NB and Camassola, M (2010). Biology and applications of mesenchymal stem cells. Sci Prog 93(Pt 2): 113-127.
17. Potian, JA, Aviv, H, Ponzio, NM, Harrison, JS and Rameshwar, P (2003). Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171: 3426-3434. (Pubitemid 37254543)
18. Biancone, L, Bruno, S, Deregibus, MC, Tetta, C and Camussi, G (2012). Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 27: 3037-3042.
19. Lim, PK, Bliss, SA, Patel, SA, Taborga, M, Dave, MA, Gregory, LA et al. (2011). Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res 71: 1550-1560.
20. Sun, AX, Crabtree, GR and Yoo, AS (2013). MicroRNAs: regulators of neuronal fate. Curr Opin Cell Biol 25: 215-221.
21. Mao, H, Lebrun, DG, Yang, J, Zhu, VF and Li, M (2012). Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets. Cancer Invest 30: 48-56.
22. Juszczak, GR and Swiergiel, AH (2009). Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies. Prog Neuropsychopharmacol Biol Psychiatry 33: 181-198.
23. Park, JM, Munoz, JL, Won, BW, Bliss, SA, Greco, SJ, Patel, SA et al. (2013). Exogenous CXCL12 activates protein kinase C to phosphorylate connexin 43 for gap junctional intercellular communication among confluent breast cancer cells. Cancer Lett 331: 84-91.
24. Cogolludo, A, Moreno, L, Frazziano, G, Moral-Sanz, J, Menendez, C, Castañeda, J et al. (2009). Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction. Cardiovasc Res 82: 296-302.
25. Kucharzewska, P, Christianson, HC, Welch, JE, Svensson, KJ, Fredlund, E, Ringnér, M et al. (2013). Exosomes reflect the hypoxic status of glioma cells and mediate hypoxiadependent activation of vascular cells during tumor development. Proc Natl Acad Sci USA 110: 7312-7317.
26. Oliva, CR, Moellering, DR, Gillespie, GY and Griguer, CE (2011). Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production. PLoS ONE 6: e24665.
27. Thery, C, Amigorena, S, Raposo, G and Clayton, A (2006). Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protocols Cell Biol 30: 3221-32229.